La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Occitanie (région administrative)785
Jean-Louis Montastruc39
Occitanie (région administrative) Sauf Jean-Louis Montastruc" 753
Jean-Louis Montastruc Sauf Occitanie (région administrative)" 7
Occitanie (région administrative) Et Jean-Louis Montastruc 32
Occitanie (région administrative) Ou Jean-Louis Montastruc 792
Corpus9014
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 32.
Ident.Authors (with country if any)Title
000347 Sibylle De Germay [France] ; Jean-Louis Montastruc [France] ; Vanessa Rousseau [France] ; Leila Chebane [France] ; Emmanuelle Bondon-Guitton [France] ; Florence Moulis [France] ; Genevieve Durrieu [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Antoine Pariente [France] ; Bernard Bégaud [France] ; François Montastruc [France]Atropinic (Anticholinergic) Burden in Parkinson's Disease.
000B02 Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
001136 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Michel Senard ; Anne Pavy-Le Traon ; Jean-Louis Montastruc ; Olivier RascolFactors related to orthostatic hypotension in Parkinson's disease.
001154 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Louis Montastruc ; Olivier RascolDo Parkinson's disease patients disclose their adverse events spontaneously?
001430 Santiago Perez-Lloret [France] ; Maria Veronica Rey [France] ; Nelly Fabre [France] ; Fabienne Ory [France] ; Umberto Spampinato [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]Do Parkinson's disease patients disclose their adverse events spontaneously?
001658 Julia Grossac [France] ; Stéphanie Ruiz [France] ; Emmanuelle Bondon-Guitton [France] ; Franck-Emmanuel Roux [France] ; Olivier Fourcade [France] ; Jean-Louis Montastruc [France] ; Thomas Geeraerts [France]Severe intracranial bleeding related to vitamin K Antagonist‐Ropinirole interaction
001722 Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
001845 Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
001B65 Jean-Louis Montastruc [France] ; Anne Charlotte Danton [France] ; Genevieve Durrieu [France] ; Isabelle Lacroix [France] ; Pascale Olivier [France] ; Agnés Sommet [France] ; Jean-Michel Senard [France]Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view
001C33 Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
002A57 Jean-Louis Montastruc [France] ; Agnès Sommet [France] ; Pascale Olivier [France] ; Haieh Bagheri [France] ; Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Christine Brefel-Courbon [France] ; Joachim Ferreira [Portugal] ; Laurent Schmitt [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France]Médicaments, maladie de Parkinson et syndromes parkinsoniens : actualités de pharmacovigilance
002A96 Karine Desboeuf [France] ; Maryse Grau [France] ; Francoise Riche [France] ; Marc Fradin [France] ; Jacques Bez [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotension
002D65 Atul Pathak [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure
002D95 Atul Pathak [France] ; Valérie Raoul [France] ; Jean-Louis Montastruc [France] ; Jean-Michel Senard [France]Adverse drug reactions related to drugs used in orthostatic hypotension : a prospective and systematic pharmacovigilance study in France
002F19 Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France]Dopaminagonists and fibrotic valvular heart disease: Further considerations
002F57 Nhan Nguyen [France] ; Vincent Pradel [France] ; Joëlle Micallef [France] ; Jean-Louis Montastruc [France] ; Olivier Blin [France]Les syndromes parkinsoniens médicamenteux
003132 Olivier Rascol [France] ; Pierre Payoux [France] ; Fabienne Ory [France] ; Joaquim J. Ferreira [France, Portugal] ; Christine Brefel-Courbon [France] ; Jean-Louis Montastruc [France]Limitations of current Parkinson's disease therapy
003155 Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
003156 Frédéric Courbon [France] ; Christine Brefel-Courbon [France] ; Claire Thalamas [France] ; Marie Jeanne Alibelli [France] ; Isabelle Berry [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
003273 Christine Brefel-Courbon [France] ; Karine Desboeuf [France] ; Claire Thalamas [France] ; Monique Galitzky [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Clinical and economic analysis of spa therapy in Parkinson's disease
003691 Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
003805 Jean-Louis Montastruc [France] ; Christine Brefel-Courbon [France] ; Jean-Michel Senard [France] ; Haleh Bagheri [France] ; Joaquim Ferreira [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France]Sleep attacks and antiparkinsonian drugs : A pilot prospective pharmacoepidemiologic study
003811 Jean-Michel Senard [France] ; Christine Brefel-Courbon [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Orthostatic hypotension in patients with Parkinson's disease : Pathophysiology and management
003840 Olivier Rascol [France] ; Joaquim J. Ferreira [Portugal] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Jean-Louis Montastruc [France]Dopamine agonists: Their role in the management of Parkinson's disease
003C14 Jean-Louis Montastruc [France] ; Cathy Chaumerliac [France] ; Karine Desboeuf [France] ; Mimosa Manika [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France]Adverse drug reactions to selegiline : A review of the French Pharmacovigilance Database
003E49 Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France]A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
004826 Jean-Louis Montastruc [France] ; Nelly Fabre [France] ; Olivier Blin [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; André Rascol [France]Does fluoxetine aggravate Parkinson's disease? A pilot prospective study
004B41 Jean-Michel Senard [France] ; Jean-Louis Montastruc [France]Adrenoceptor regulation in orthostatic hypotension during autonomic failure
004D84 Jean-Michel Senard [France] ; Bernard Chamontin [France] ; André Rascol [France] ; Jean-Louis Montastruc [France]Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension
005523 Alain Villeneuve ; Michel Berlan [France] ; Max Lafontan ; Claudine Caranobe [France] ; Bernard Boneu [France] ; André Rascol [France] ; Jean-Louis Montastruc [France]Platelet alpha2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment
005920 Jean-Louis Montastruc [France] ; Agnès Sommet ; Pascale Olivier ; Haleh Bagheri ; Mireille Gony ; Maryse Lapeyre-Mestre ; Christine Brefel-Courbon ; Joachim Ferreira ; Laurent Schmitt ; Jean-Michel Senard ; Olivier Rascol[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance].
005956 Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Christine Brefel-Courbon ; Jean-Louis Montastruc ; Olivier RascolPrevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024